We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Heat Biologics Inc is a biotechnology business with stocks listed in the US. Heat Biologics shares (HTBX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$3.93 – a decrease of 9.66% over the previous week. Here's how to invest if you're based in Australia.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | US$3.9198 - US$17 |
|---|---|
| 50-day moving average | US$5.3458 |
| 200-day moving average | US$6.546 |
| Target price | US$20.67 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | US$-1.152 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $3.93
| 1 week (2021-11-29) | -9.66% |
|---|---|
| 1 month (2021-11-05) | -26.54% |
| 3 months (2021-09-03) | -39.82% |
| 6 months (2021-06-04) | -38.98% |
| 1 year (2020-12-04) | -47.04% |
|---|---|
| 2 years (2019-12-06) | 24.76% |
| 3 years (2018-12-06) | -57.79% |
| 5 years (2016-12-06) | -53.21% |
| Revenue TTM | US$2.1 million |
|---|---|
| Gross profit TTM | US$-9,990,926 |
| Return on assets TTM | -13.53% |
| Return on equity TTM | -23.16% |
| Profit margin | 0% |
| Book value | 4.967 |
| Market capitalisation | US$105.9 million |
TTM: trailing 12 months
We're not expecting Heat Biologics to pay a dividend over the next 12 months.
Heat Biologics's shares were split on a 1:7 basis on 10 December 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heat Biologics shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Heat Biologics shares which in turn could have impacted Heat Biologics's share price.
Over the last 12 months, Heat Biologics's shares have ranged in value from as little as US$3.9198 up to US$17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heat Biologics's is 0.4379. This would suggest that Heat Biologics's shares are less volatile than average (for this exchange).
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer; and HS-130 that is in phase I clinical trial for the treatment of advanced solid tumors. Its preclinical stage products include PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25; TNFRSF25 modulators for various immunotherapy approaches; and COVID-19 vaccine. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
Everything we know about the Allup Silica IPO, plus information on how to buy in.
From where the no-makeup makeup look meets the model off duty vibe, we've put together a range of no-fuss products you'll love.
Every man wanted her – 1 man dared to love her.
Manchester United are scrambling to stay in touch with the top 4 as they host Arsenal this week
From toys to socks to beauty items, these are the top 12-day advent calendars you can still enjoy in the lead up to Christmas.
Steps to owning and managing McDonald's shares from in Australia.
Reputation + Christmas parties: could it be the potential volcano erupting leaving rands, families and individuals to deal with the fallout?
Insurtech Flip has shaken up the insurance industry by launching the first on-demand injury cover in the country.
Everything we know about the Qualitas Limited IPO, plus information on how to buy in.
